Investigation on the expression of IGF-I protein in insulin-resistant rat brain

Authors

Azita Parvaneh Tafreshi1, Razieh jalal2, Shamila Darvishalipoor1,*, Hoori Sepehri3, Khosrow Adeli4
1Department of Basic Sciences in Biotechnology, The National Research Institute of Genetic Engineering and Biotechnology, Tehran, IR.Iran
2Department of Chemistry, Ferdowsi University, Mashad, Tehran, IR.Iran
3Department of Physiology, Faculty of Sciences, Tehran, IR.Iran
4Department of Clinical Biochemistry, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
*Corresponding Author: Department of Basic Sciences in Biotechnology, The National Research Institute of Genetic Engineering and Biotechnology, Tehran, IR.Iran Email: [email protected]

International Journal of Endocrinology and Metabolism:Vol. 8, issue 3; e94645
Published online:Aug 31, 2010
Article type:Research Article
Received:May 29, 2019
Accepted:Aug 31, 2010
How to Cite:Parvaneh Tafreshi A, jalal R, Darvishalipoor S, Sepehri H, Adeli K. Investigation on the expression of IGF-I protein in insulin-resistant rat brain. Int J Endocrinol Metab. 2010;8(3):e94645. doi:

Abstract

Diabetes Insulin Resistance Brain IGF-I Background: In insulin-resistance animal models, insulin uptake from the periphery to the brain is impaired. Although brain insulin is not involved in glucose transfer to the neurons, it is required for neuron survival and function, mediated by binding to insulin receptors. Furthermore, an insulin homologue called insulin-like growth factor (IGF-I), which is abundantly expressed in mature neurons and acts in parallel with insulin in the brain, has the ability to bind to the insulin receptor and trigger the signal transduction pathway. Objectives: Although reduced levels of brain insulin and serum IGF-I have been reported during insulin resistance, no data is available on IGF-I levels in the brain. In this study, we sought to investigate if the expression of IGF-I is also altered in brains of insulin-resistant rats. Materials and Methods: Wistar rats were given 10% fructose in their drinking water for up to 4 months to induce insulin resistance. The rats were then killed and perfused with PFA 4%; then, there brains were excised, sectioned, and examined for immunoreactivity of IGF-I. Results: Our results showed an increased intensity of IGF-I in most brain areas of the insulin-resistant rats. Conclusions: Altogether, an increased expression of IGF-I in the brain could be a compensatory mechanism and substitute for low levels or lack of insulin in the brains of insulin-resistant animals.

Fulltext

This part is available in the PDF file.

References

  • 1.
    The references are available in the PDF file.

Copyright

© 2010, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

31
Jan
2009

Relationship Between Insulin like Growth Factor-1 and Leptin in Type II Diabetic Patients

N Zarghami,
G Mohammad Zadeh,
P Karimi

Zarghami N, Mohammad Zadeh G, Karimi P. Relationship Between Insulin like Growth Factor-1 and Leptin in Type II Diabetic Patients. Int J Endocrinol Metab. 2009;7(1):. doi:

7
Jun
2022

Insulin Can Improve the Normal Function of the Brain by Preventing the Loss of the Neurons

Ali Asghar Peyvandi,
Hojjat Allah Abbaszadeh,
Mohammad Golshan Tafti,
Mohammad-Amin Abdollahifar,
Hojjat-allah Abbaszadeh

Peyvandi AA, Abbaszadeh HA, Golshan Tafti M, Abdollahifar M, Abbaszadeh H. Insulin Can Improve the Normal Function of the Brain by Preventing the Loss of the Neurons. J Cell Mol Anesth. 2022;7(4):e149750. doi: https://doi.org/10.22037/jcma.v7i4.38324

31
Jan
2004

Study of the Correlation Between IGF-I and Glycaemic Control in Type 1 Diabetes

Zarghami N,
Khosrowbeygi A,
Eshtiaghi R,
Dayer D

N Z, A K, R E, D D. Study of the Correlation Between IGF-I and Glycaemic Control in Type 1 Diabetes. Int J Endocrinol Metab. 2004;2(1):. doi:

31
Jul
2011

Insulin, Insulin-like Growth Factor-1 and Neurodegeneration

Vincenza Cifarelli,
Drew Hays,
Stephen D. Hursting

Cifarelli V, Hays D, Hursting SD. Insulin, Insulin-like Growth Factor-1 and Neurodegeneration. Int J Endocrinol Metab. 2011;9(3):. doi: https://doi.org/10.5812/Kowsar.1726913X.3486

2
Jul
2022
A Possible Novel Effect for Dapagliflozin in the Management of Subcutaneous Insulin Resistance Syndrome: A Report of Two Cases

A Possible Novel Effect for Dapagliflozin in the Management of Subcutaneous Insulin Resistance Syndrome: A Report of Two Cases

Nabil W. G. Sweis,
Ahmad Albanna,
Rama Alhasoun,
Ayman Zayed

Sweis NWG, Albanna A, Alhasoun R, Zayed A. A Possible Novel Effect for Dapagliflozin in the Management of Subcutaneous Insulin Resistance Syndrome: A Report of Two Cases. Int J Endocrinol Metab. 2022;20(3):e126350. doi: https://doi.org/10.5812/ijem-126350

More by these authors

Azita Parvaneh TafreshiPubMedScholar
Razieh jalalPubMedScholar
Shamila DarvishalipoorPubMedScholar
Hoori SepehriPubMedScholar
Khosrow AdeliPubMedScholar
Share
Cited by
Metrics